12/2
08:06 am
lexx
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
11/25
08:05 am
lexx
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Lexaria Bioscience Corp. (NASDAQ: LEXX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.